FDA has created a special emergency program for possible therapies, the Coronavirus Treatment Acceleration Program (CTAP). It uses every available method to move new treatments to patients as quickly as possible, while at the same time finding out whether they are helpful or harmful.

JAMA published an article on Preserving Clinical Trial Integrity During the Coronavirus Pandemic.

JAMA published an article on Preserving Clinical Trial Integrity During the Coronavirus Pandemic.

On 18 March 2020 teleconference of global regulators convened jointly by the European Medicines Agency (EMA) and US Food and Drug Administration (FDA) under the auspices of the International Coalition of Medicines Regulatory Authorities (ICMRA)

On 18 March 2020 teleconference of global regulators convened jointly by the European Medicines Agency (EMA) and US Food and Drug Administration (FDA) under the auspices of the International Coalition of Medicines Regulatory Authorities (ICMRA)

The guideline is directed to Industry, Investigators, and Institutional Review Boards.

The guideline is directed to Industry, Investigators, and Institutional Review Boards.

A lot of clinical research started against COVID-19. Some of them are new, some of them are old drug and vaccines.

Vaccines:

1. Altimmune’s intranasal coronavirus vaccine
2. INO-4800 by Inovio Pharmaceuticals and Beijing Advaccine Biotechnology
3. NP-120 (Ifenprodil) by Algernon Pharmaceuticals
4. APN01 by University of British Columbia and APEIRON Biologics
5. mRNA-1273 vaccine by Moderna and Vaccine Research Center
6. Avian Coronavirus Infectious Bronchitis Virus
   Read More…

A lot of clinical research started against COVID-19. Some of them are new, some of them are old drug and vaccines.

Vaccines:

1. Altimmune’s intranasal coronavirus vaccine
2. INO-4800 by Inovio Pharmaceuticals and Beijing Advaccine Biotechnology
3. NP-120 (Ifenprodil) by Algernon Pharmaceuticals
4. APN01 by University of British Columbia and APEIRON Biologics
5. mRNA-1273 vaccine by Moderna and Vaccine Research Center
6. Avian Coronavirus Infectious Bronchitis Virus
   Read More…

One study was initiated by Gilead in Spain and looks for IV Remdesevir in 2 age cohorts. The other study in USA compares Remdesevir with Placebo. The third study in Europe compares Remdesivir with an HIV drug combination (Ritonavir/Lopinavir) and HIV drug combination + IFN-Beta arms. The vaccine study is done in USA.